Compounds > gamma-aminobutyric acid
Page last updated: 2024-10-16

gamma-aminobutyric acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

gamma-aminobutyric acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koh, M1
Lee, JC1
Min, C1
Moon, A1

Other Studies

1 other study available for gamma-aminobutyric acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
A novel metformin derivative, HL010183, inhibits proliferation and invasion of triple-negative breast cancer cells.
    Bioorganic & medicinal chemistry, 2013, Apr-15, Volume: 21, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Ani

2013